Long Term Outcomes With Alemtuzumab Induction Therapy for Deceased and Living Renal Transplant Recipients. A Single Center Experience

被引：0
|
作者：
Vaitla, P. [1 ]
Patel, U. [1 ]
Cruz, A. [1 ]
Guisti, S. [1 ]
Moiz, A. [1 ]
Catherine, C. -S. [1 ]
Cohen, A. [1 ]
Loss, G. [1 ]
Bohorquez, H. [1 ]
Carmody, I. [1 ]
Reichman, T. [1 ]
Bruce, D. [1 ]
Anders, S. [1 ]
Garces, J. [1 ]
机构：
[1] Ochsner Clin Fdn, New Orleans, LA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2015年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1259
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Long-term critical issues in pediatric renal transplant recipients: a single-center experience
    Harambat, Jerome
    Ranchin, Bruno
    Bertholet-Thomas, Aurelia
    Mestrallet, Guillaume
    Bacchetta, Justine
    Badet, Lionel
    Basmaison, Odile
    Bouvier, Raymonde
    Demede, Delphine
    Dubourg, Laurence
    Floret, Daniel
    Martin, Xavier
    Cochat, Pierre
    TRANSPLANT INTERNATIONAL, 2013, 26 (02) : 154 - 161
  • [32] OUTCOMES IN RENAL TRANSPLANT RECIPIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A SINGLE CENTER EXPERIENCE
    Castro, Ana
    Guardado, Vanda
    Malheiro, Jorge
    Martins, La Salete
    Almeida, Manuela
    Pedroso, Sofia
    Dias, Leonidio
    Henriques, Antonio Castro
    Cabrita, Antonio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [33] Two Center Experience of Recurrent Lupus Nephritis in Renal Transplant Recipients.
    Peram, Veni J.
    Patel, Nilang
    Murray, Brian
    Pankewycz, Oleh
    Panesar, Mandeep
    Venuto, Rocco
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 583 - 584
  • [34] Long Term (5-Year) Outcomes Using Subcutaneous Alemtuzumab for Induction in Highly-HLA-Sensitized (HS) Kidney Transplant Recipients.
    Chang, G.
    Vo, A.
    Choi, J.
    Kahwaji, J.
    Villicana, R.
    Peng, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 429 - 429
  • [35] Long-Term Outcomes of Older Kidney-Transplant Recipients: A Single-Center Experience
    Sultan, S.
    Aull, M.
    Lubetzky, M.
    Watkins, A.
    Kapur, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 967 - 968
  • [36] Alemtuzumab Induction Results in Higher Rates of Leucopenia and Opportunistic Viral Infections in Renal Transplant Recipients.
    Chua, E.
    Bhensdadia, N.
    Posadas, M.
    Taber, D.
    Bunke, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 427 - 427
  • [37] Impact of Campath-1H (Alemtuzumab) induction on CMV infection in renal transplant recipients.
    Singh, N.
    Murray, B.
    Gundroo, A.
    Qazi, Y.
    Hasan, M.
    Khalil, F.
    Blessios, G.
    Tornatore, K.
    Venuto, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 522 - 522
  • [38] Elevated De Novo Donor Specific Antibody After Alemtuzumab Induction in Renal Transplant Recipients.
    Fabbri, K.
    Descourouez, J.
    Jorgenson, M.
    Redfield, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 619 - 619
  • [39] Locoregional Therapy and Long-Term Post-Transplant Outcomes for HCC Liver Transplant Recipients.
    Ishaque, T.
    Weeks, S. R.
    Kolarich, A.
    Ruck, J.
    Garonzik-Wang, J.
    Segev, D.
    Massie, A.
    King, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 820 - 820
  • [40] Elevated de novo donor specific antibody after alemtuzumab induction in renal transplant recipients.
    Jorgenson, Margaret
    Fose, Jillian
    Redfield, Robert
    Fabbri, Kassandra
    PHARMACOTHERAPY, 2016, 36 (07): : E103 - E104
12345